COVINGTON & BURLING LLP for PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Part D/non-interference; Biopharmaceutical innovation and patent policy issues; Protecting Medicare from Executive Action Act of 2017 (S. 251); STRONGER Patents Act (S.1390); Medicare Part D coverage gap closure.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GARY HEIMBERG | — |
| RICHARD HERTLING | — |
| GABRIEL NEVILLE | — |
Health Issues HCR
Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (H.R. 2851/S. 1327); The Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act (i.e., the "SCREEN Act")(H.R. 5228); Opioid Crisis Response Act of 2018 (S. 2680); Expanding Access to Low Cost Generic Drugs Act (S. 2476); Preserve Access to Affordable Generics Act (S. 124); Regulatory exclusivity; Improving Access To Affordable Prescription Drugs Act (S. 771/H.R. 1776); Legislation on drug labeling; Comprehensive Addiction Resources Emergency Act (CARE Act)(S. 2700/HR 5545); SOUND Disposal and Packaging Act (HR 5687); Biologics patent settlements; Long-Term Opioid Efficacy Act of 2018 (HR 5811); SAFETY Act of 2018 (H.R. 5803); Insulin pricing; H.R. 5752, the Stop Illicit Drug Importation Act of 2018; proposed legislation regarding tableting and encapsulating opioid products; Drug Importation; Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act (HR 5247/S. 204; CREATES Act (HR 2212/S. 974)
| Lobbyist | Covered position, as disclosed |
|---|---|
| KRISTA CARVER | — |
| THOMAS COSGROVE New | — |
| GARY HEIMBERG | — |
| RICHARD HERTLING | — |
| RICHARD F KINGHAM | — |
| GABRIEL NEVILLE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.